Literature DB >> 30539195

[Genetic risk factors for a second neoplasm in children who have survived a first malignant disease].

Martin G Sauer1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30539195     DOI： 10.1007/s00066-018-1409-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.

Authors:  Mandy L Ballinger; Ana Best; Phuong L Mai; Payal P Khincha; Jennifer T Loud; June A Peters; Maria Isabel Achatz; Rubens Chojniak; Alexandre Balieiro da Costa; Karina Miranda Santiago; Judy Garber; Allison F O'Neill; Rosalind A Eeles; D Gareth Evans; Eveline Bleiker; Gabe S Sonke; Marielle Ruijs; Claudette Loo; Joshua Schiffman; Anne Naumer; Wendy Kohlmann; Louise C Strong; Jasmina Bojadzieva; David Malkin; Surya P Rednam; Elena M Stoffel; Erika Koeppe; Jeffrey N Weitzel; Thomas P Slavin; Bita Nehoray; Mark Robson; Michael Walsh; Lorenzo Manelli; Anita Villani; David M Thomas; Sharon A Savage
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

2.  Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.

Authors:  Alexander M Aravanis; Mark Lee; Richard D Klausner
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 3.  PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Authors:  Kris Ann P Schultz; Surya P Rednam; Junne Kamihara; Leslie Doros; Maria Isabel Achatz; Jonathan D Wasserman; Lisa R Diller; Laurence Brugières; Harriet Druker; Katherine A Schneider; Rose B McGee; William D Foulkes
Journal:  Clin Cancer Res       Date:  2017-06-15       Impact factor: 12.531

4.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Authors:  Anita Villani; Ari Shore; Jonathan D Wasserman; Derek Stephens; Raymond H Kim; Harriet Druker; Bailey Gallinger; Anne Naumer; Wendy Kohlmann; Ana Novokmet; Uri Tabori; Marta Tijerin; Mary-Louise C Greer; Jonathan L Finlay; Joshua D Schiffman; David Malkin
Journal:  Lancet Oncol       Date:  2016-08-05       Impact factor: 41.316

Review 5.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Authors:  Christian P Kratz; Maria Isabel Achatz; Laurence Brugières; Thierry Frebourg; Judy E Garber; Mary-Louise C Greer; Jordan R Hansford; Katherine A Janeway; Wendy K Kohlmann; Rose McGee; Charles G Mullighan; Kenan Onel; Kristian W Pajtler; Stefan M Pfister; Sharon A Savage; Joshua D Schiffman; Katherine A Schneider; Louise C Strong; D Gareth R Evans; Jonathan D Wasserman; Anita Villani; David Malkin
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.